Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

QR Code

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Abstract Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of each of these agents to the global activity of th...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel García-Saenz, Maria del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez-Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/6320cb09619d46bdb0b5fd843bc4c5e3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
par: Abdel Kader Y, et autres
Publié: (2013)

Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
par: Bunte RM, et autres
Publié: (2012)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts
par: Sreeranganathan M, et autres
Publié: (2017)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
par: Sreeranganathan M, et autres
Publié: (2019)

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
par: Stijn Moens, et autres
Publié: (2021)

Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
par: Dolores Hernán Pérez de la Ossa, et autres
Publié: (2013)

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
par: V. La, et autres
Publié: (2017)

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
par: Bo Gao, et autres
Publié: (2018)

Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
par: Sofia C. Nunes, et autres
Publié: (2018)

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
par: Thomas M, et autres
Publié: (2017)

Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
par: Viscarra,Tamara, et autres
Publié: (2019)

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting
par: Mudad R, et autres
Publié: (2017)

The chemotherapeutic drug carboplatin affects macrophage responses to LPS and LPS tolerance via epigenetic modifications
par: Atsadang Boonmee, et autres
Publié: (2021)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
par: Sofia M. Saraiva, et autres
Publié: (2021)

How nanotechnology can enhance docetaxel therapy
par: Zhang L, et autres
Publié: (2013)

Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
par: V. La, et autres
Publié: (2021)

Next-generation sequence analysis of cancer xenograft models.
par: Fernando J Rossello, et autres
Publié: (2013)

Dimensiones discursivas en torno al voto electrónico
par: Barrientos del Monte,Fernando
Publié: (2007)

Crecimiento e institucionalización de la ciencia política en México
par: BARRIENTOS DEL MONTE,FERNANDO
Publié: (2015)

Estudios en memoria del Profesor Dr. Carlos Sáez homenaje /
par: González de la Peña, María del Val
Publié: (2007)

A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
par: Chengcheng Gong, et autres
Publié: (2017)

NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo
par: Harada M, et autres
Publié: (2012)

Trayectoria de la reforma de la función pública española (1977-1981) : exposición y aportaciones críticas /
par: Gonzaléz-Haba Guisado, Vicente María
Publié: (1984)

La función pública local en el marco de la reforma burocrática española /
par: González-Haba Guisado, Vicente María
Publié: (1985)

Recensiones y noticias de libros /
par: González-Haba Guisado, Vicente María
Publié: (2003)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
par: Oh KS, et autres
Publié: (2016)

Assessing body weight as a predictor of vulnerability for extinction in marine invertebrates
par: González-Valdovinos,Marcela Isabel, et autres
Publié: (2019)

Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
par: Vamsidhar Velcheti, et autres
Publié: (2021)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
par: Victoria J Sinibaldi
Publié: (2008)

Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines.
par: Franziska Weiner, et autres
Publié: (2021)

Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
par: Melica Nourmoussavi Brodeur, et autres
Publié: (2021)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
par: Mary L Disis, et autres
Publié: (2021)

First‐line nab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Results of the NEPTUN study
par: Tobias Dechow, et autres
Publié: (2021)

Targeted therapy of human leukemia xenografts in immunodeficient zebrafish
par: Ranganatha R. Somasagara, et autres
Publié: (2021)

Recurrent Structural and Thematic Traits in Jeanette Winterson's "The Passion" and "Sexing the Cherry": Time, Space and the Construction of Identity
par: Asensio Aróstegui, María del Mar
Publié: (2003)

Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
par: Hua H, et autres
Publié: (2017)

Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer
par: Seguin C, et autres
Publié: (2017)

The influence of bile salt on the chemotherapeutic response of docetaxel-loaded thermosensitive nanomicelles
par: Kim DW, et autres
Publié: (2014)

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
par: Huang L, et autres
Publié: (2015)

Patient-derived xenografts and organoids model therapy response in prostate cancer
par: Sofia Karkampouna, et autres
Publié: (2021)